Vasopressin receptor antagonist
Results: 4
# | Item |
---|---|
1![]() | FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date: 13 September 2012Add to Reading ListSource URL: www.fda.govLanguage: English |
2![]() | Cardiokine Biopharma, LLC Lixivaptan Briefing Document NDA 203,009 Page 1 of 61Add to Reading ListSource URL: www.fda.govLanguage: English |
3![]() | The Targeting Acute Congestion with Tolvaptan In Congestive Heart Failure Study TACTICS-HF Felker GM, Adams KF, Cole RT, Patel CB, Egnaczyk G, Mentz RJ, Fiuzat M, and O’Connor CM on behalf of the TACTICS InvestigatorsAdd to Reading ListSource URL: www.hfsa.orgLanguage: English - Date: 2013-10-11 12:59:07 |
4![]() | ANNEX I SUMMARY OF PRODUCT CHARACTERISTICSAdd to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2013-08-29 09:13:53 |